Medium urgency

CVS to pay $36.5 million to CT, 35 other states settle false insulin pen Medicaid claims - ctinsider.com

Detected September 2, 2026 · in Pharmacy & Controlled Substances

CVS to pay $36.5 million to settle false Medicaid claims regarding insulin pens across 36 states, including Connecticut.

Aforeworn detected this change in the Pharmacy & Controlled Substances space on September 2, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies. should confirm how it applies to their specific situation before acting. There is a time constraint attached: N/A. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed. Regulated niches like Pharmacy & Controlled Substances move faster than most operators can track by hand, which is why Aforeworn watches the official sources for you and flags every material change the moment it appears.

What changed

CVS's settlement indicates increased scrutiny and potential compliance risks for pharmacies regarding Medicaid claims.

Who it affects

Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies.

What you must do

Review and ensure compliance with Medicaid billing practices to avoid similar claims.

Deadline

N/A

Source: https://news.google.com/rss/articles/CBMimAFBVV95cUxORFQwTlhraHBhaHlJa3hYaUhOU2NXT0ZnZ3RTWnBObzhDZkYwWVdrdHdaYUQ1R25YcHFtVGJyNGg3VVdObDN3RHBhN3NNWk8xN2xlQ01hVWpuMGNsVWRpZ3hOOEdCQmVmREgwTnVQakRqM3ZDcEVyb1ppdGhDdmtqdV9Ea1VabkhhbG1SbXFzSDFPZFBYTEQyNA?oc=5

Never miss a change like this again

Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Pharmacy & Controlled Substances